All over the world, the most common malignancy in women is breast cancer. Breast cancer is also a significant factor of death in women. In 2020, approximately 2.3 million cases of breast cancer were newly diagnosed in women globally, and approximately 685,000 people died. Breast cancer incidence varies by region around the world, but it…
ONCOLOGIE Template
Write in a clean editor, then format for ONCOLOGIE in one click — DocuGuru applies the official Springer Nature template with superscript references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the ONCOLOGIE format
ONCOLOGIE is a peer-reviewed journal published by Springer Nature, covering Health, Medicine and Society, Healthcare Systems and Practices, Cancer Treatment and Pharmacology.
| Publisher | Springer Nature |
|---|---|
| Reference style | Superscript numbered (Nature) Superscript — small raised numerals in the text 1. Smith, A., Jones, B. & Lee, C. A representative article title. ONCOLOGIE 12, 45–58 (2023).
Formats any DOI in ONCOLOGIE style. No sign-up. |
| Publishes research in | Health, Medicine and Society Healthcare Systems and Practices Cancer Treatment and Pharmacology Breast Cancer Treatment Studies Colorectal Cancer Treatments and Studies |
| ISSN | 1292-3818 |
| Citation impact (2-yr) | 1.7 |
| h-index | 21 |
| i10-index | 80 |
| Total citations | 3,720 |
| Open access | Yes |
| Top institutions publishing here | Institut Gustave Roussy |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in ONCOLOGIE per year
Citation impact of ONCOLOGIE by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in ONCOLOGIE
The incidence and mortality of lung cancer rank top three of all cancers worldwide. Accounting for 85% of the total number of lung cancer, non-small cell lung cancer (NSCLC) is an important factor endangering human health. Re... | Find, read and cite all the research you need on Tech Science Press
Abstract Cancer is the second leading cause of death worldwide. Although multiple new cancer treatments have emerged in recent years, drug therapy, mainly comprising chemotherapy, targeted therapy, and immunotherapy, remains the most common approach. The multidrug resistance (MDR) of cancer cells to various treatments remains a challenge. Scientists have always focused on the acquired drug…
Objectives: Lung cancer is a common and malignant tumor in adults and ranks first in the incidence and mortality of the top five malignant tumors in China. Our previous studies have shown that QYSL prescription can balance lung cancer mice Th1/Th2 and inhibit tumor cell immune escape. Here, we examined the effects of QYSL on…
Lung cancer is the most common malignant tumor with the highest morbidity and mortality in the world, and non-small cell lung cancer (NSCLC) accounts for the vast majority of cases. At present, its main treatment methods are still traditional surgery, radiotherapy and chemotherapy, with disadvantages such as a high recurrence rate and limited effectiveness. Therefore,…